• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ICAD

ICAD

iCAD, Inc.

NASDAQHealthcareMedical - DevicesUS

USD3.87

+0.14 (+3.75%)

Company Profile

CEO

Dana R. Brown

IPO Date

1984-12-13

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.87

Prev. Close

$3.73

Day Low

$3.87

Day High

$3.87

52W Low

$1.19

52W High

$4.01

Market Cap

$0.11B

Volume

0.19M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

55.3%

Avg Negative

2.6%

Avg Neutral

42.2%

News Feed

iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5

GlobeNewsWire·7/22/2021·↑ positive

iCAD's ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval

GlobeNewsWire·6/14/2021·↑ positive

iCAD: Cancer Detection And Therapy Solutions Company Offers Stable Upside

Seeking Alpha·5/19/2021·↑ positive

iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25

GlobeNewsWire·5/17/2021·↑ positive

iCAD, Inc. (ICAD) CEO Michael Klein on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·4/29/2021·↓ negative

Icad (ICAD) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·4/28/2021·↑ positive

iCAD Reports Financial Results for First Quarter Ended March 31, 2021

GlobeNewsWire·4/28/2021·↑ positive

iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition

GlobeNewsWire·4/5/2021·↑ positive

iCAD Shares On The Rise After FDA Approval For Third Version Of ProFound AI For 3D Mammography

Benzinga·3/16/2021·↑ positive

ICAD Stock Price Increases Over 15% Pre-Market: Why It Happened

Pulse2·3/16/2021·↑ positive